High-dose therapy and autologous stem-cell transplantation can improve event-free survival for indolent lymphoma: a study using patients as their own controls (Q79366672)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 January 2007

Language	Label	Description	Also known as
English	High-dose therapy and autologous stem-cell transplantation can improve event-free survival for indolent lymphoma: a study using patients as their own controls	scientific article published on 01 January 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111421%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

High-dose therapy and autologous stem-cell transplantation can improve event-free survival for indolent lymphoma: a study using patients as their own controls (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111421%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Nicolas Mounier

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111421%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111421%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Stéphane Vignot

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111421%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Jérôme Larghero

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111421%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Pauline Brice

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111421%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Cédric de Bazelaire

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111421%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Marjan Ertault

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111421%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Josette Brière

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111421%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Isabelle Madelaine

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111421%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Christian Gisselbrecht

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111421%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111421%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111421%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

109

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111421%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111421%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

60-67

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111421%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

High-dose therapy for indolent lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Follicular lymphoma international prognostic index.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Current treatment of follicular non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European Bone Marrow Transplant Registry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy followed by bone marrow transplantation for relapsed follicular non-Hodgkin's lymphoma. Dutch HOVON Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lympho

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimating late adverse events using competing risks after autologous stem-cell transplantation in aggressive non-Hodgkin lymphoma patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for the clinical outcome of patients with follicular lymphoma following high-dose therapy and peripheral blood stem cell transplantation (PBSCT)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma: updated results of the Utrecht experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow processing using the fenwal CS-3000 plus blood cell separator: results of 99 procedures

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved survival of follicular lymphoma patients in the United States.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP al

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiproliferative activity of a humanized anti-CD74 monoclonal antibody, hLL1, on B-cell malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Radioimmunotherapy of non-Hodgkin lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

131I-tositumomab therapy as initial treatment for follicular lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonmyeloablative stem cell transplantation for lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22383

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.22383

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111421%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17111421%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79366672&oldid=1599838712"